Financing type: best efforts prospectus offering
Gross proceeds: $2,999,999.80
Offering: 8,571,428 units with 8,571,428 warrants attached
Offering price: 35 cents per unit
Warrant exercise terms: 50 cents per listed share until Dec. 12, 2026
Commission in securities: Research Capital Corp. (lead), 514,286 warrants
Commission terms: Each non-transferable agent's warrant is exercisable at 35 cents for a two-year period.
Disclosure: Refer to the prospectus dated Dec. 4, 2024, and company's news releases dated Dec. 2, 2024, and Dec. 12, 2024.
© 2025 Canjex Publishing Ltd. All rights reserved.